Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System

INTRODUCTION: This study aimed to evaluate the clinical and economic outcomes of implementing a Clostridiodes difficile infection (CDI) Treatment Optimization and Access Pathway (treatment pathway) directing first-line use of fidaxomicin for CDI. METHODS: This was a retrospective, quasi-experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: McDaniel, Lauren F., White, Melissa N., Obi, Engels N., Kohinke, Rose M., Lockhart, Ellen Rachel S., Chipriano, Damian J., Chen, Yiyun, Everson, Nathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868207/
https://www.ncbi.nlm.nih.gov/pubmed/35854204
http://dx.doi.org/10.1007/s40121-022-00665-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868207/
https://www.ncbi.nlm.nih.gov/pubmed/35854204
http://dx.doi.org/10.1007/s40121-022-00665-1

Ejemplares similares